These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8280418)
21. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255 [TBL] [Abstract][Full Text] [Related]
23. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442 [TBL] [Abstract][Full Text] [Related]
24. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain. Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Brugal MT; Gac Sanit; 2013; 27(4):338-43. PubMed ID: 23578527 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Bodsworth NJ; Cunningham P; Kaldor J; Donovan B Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359 [TBL] [Abstract][Full Text] [Related]
26. Anonymous HIV surveillance in Saughton Prison, Edinburgh. Bird AG; Gore SM; Jolliffe DW; Burns SM AIDS; 1992 Jul; 6(7):725-33. PubMed ID: 1503691 [TBL] [Abstract][Full Text] [Related]
27. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Balogun MA; Ramsay ME; Parry JV; Donovan L; Andrews NJ; Newham JA; McGarrigle C; Harris KA; Teo CG Sex Transm Infect; 2003 Aug; 79(4):301-6. PubMed ID: 12902580 [TBL] [Abstract][Full Text] [Related]
28. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432 [TBL] [Abstract][Full Text] [Related]
29. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Crampin AC; Lamagni TL; Hope VD; Newham JA; Lewis KM; Parry JV; Gill ON Epidemiol Infect; 1998 Oct; 121(2):381-6. PubMed ID: 9825789 [TBL] [Abstract][Full Text] [Related]
30. Recent trends in the HIV epidemic among injecting drug users in Northern Italy, 1993-1999. Sabbatini A; Carulli B; Villa M; Corrêa Leite ML; Nicolosi A; AIDS; 2001 Nov; 15(16):2181-5. PubMed ID: 11684938 [TBL] [Abstract][Full Text] [Related]
31. Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93. Nicoll A; Hutchinson E; Soldan K; McGarrigle C; Parry JV; Newham J; Mahoney A; Nicholas S; Heptonstall J; Gill ON Commun Dis Rep CDR Rev; 1994 Sep; 4(10):R115-20. PubMed ID: 7527276 [TBL] [Abstract][Full Text] [Related]
32. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555 [TBL] [Abstract][Full Text] [Related]
33. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. Desenclos JC; Papaevangelou G; Ancelle-Park R AIDS; 1993 Oct; 7(10):1371-7. PubMed ID: 8267911 [TBL] [Abstract][Full Text] [Related]
34. Low and stable prevalence of HIV among drug injectors in Glasgow. Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. Dufour A; Alary M; Poulin C; Allard F; Noël L; Trottier G; Lépine D; Hankins C AIDS; 1996 Aug; 10(9):1009-15. PubMed ID: 8853735 [TBL] [Abstract][Full Text] [Related]
36. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. Liu Y; Liu Y; Zou X; Chen W; Ling L BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214 [TBL] [Abstract][Full Text] [Related]
37. Survey of risk behaviour and HIV prevalence in an English prison. Edwards A; Curtis S; Sherrard J Int J STD AIDS; 1999 Jul; 10(7):464-6. PubMed ID: 10454182 [TBL] [Abstract][Full Text] [Related]
38. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Sutton AJ; Gay NJ; Edmunds WJ Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627 [TBL] [Abstract][Full Text] [Related]
39. How many people in England and Wales risk infection from injecting drug use? Durante AJ; Heptonstall J Commun Dis Rep CDR Rev; 1995 Mar; 5(3):R40-4. PubMed ID: 7536591 [TBL] [Abstract][Full Text] [Related]
40. Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico. Robles RR; Colón HM; Díaz N; Cancel LI; MacGowan R; Cole GE; Allen DM Int J Epidemiol; 1994 Jun; 23(3):595-601. PubMed ID: 7960388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]